← Azimuth Daily
Capturing data…
Capturing data…
WED, 21 OCT · 81 ITEMS
"Veradermics' oral hair-loss drug shows hair growth in late-stage study" — Reuters (via Google News) · Science & Medicine
Veradermics announced positive results from a trial of , an oral extended-release pill, for male . Over 500 men taking the drug showed statistically significant increases in compared to placebo after six months, suggesting it could become a convenient oral alternative to topical minoxidil.
The claim is based on a company press release and reported by Reuters, so it's solid as a report of Veradermics' own data. However, the trial results have not yet been peer-reviewed or published in a medical journal, and the drug is not yet approved by regulators.
Genuinely new — reported on October 19, 2026, the same day as the company's announcement and the Reuters article.